This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
marijuana: Archive
Should You Buy TLRY Stock After Encouraging Q1 Results?
by Sundeep Ganoria
Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
by Sundeep Ganoria
Curaleaf's shares have soared over 200% on renewed legalization optimism, but domestic weakness and profit hurdles cloud the outlook.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical
From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects
by Aparajita Dutta
Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism.
MJPositive Net Change TLRYPositive Net Change YOLOPositive Net Change CNBSPositive Net Change MSOSPositive Net Change WEEDPositive Net Change
marijuana
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
by Sundeep Ganoria
Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.
CGCPositive Net Change TLRYPositive Net Change VFFPositive Net Change
marijuana medical
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment
by Sundeep Ganoria
Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
JAZZNegative Net Change ACBPositive Net Change GTBIFPositive Net Change
biotechs marijuana medical
Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?
by Sundeep Ganoria
GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.
TLRYPositive Net Change GTBIFPositive Net Change CURLFPositive Net Change
marijuana medical
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
by Sundeep Ganoria
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
TLRYPositive Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change
marijuana
Cannabis Stock CRON Trades Near 52-Week High: How to Play
by Sundeep Ganoria
Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.
CRONPositive Net Change TLRYPositive Net Change HITINo Net Change CURLFPositive Net Change
marijuana medical
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
by Sundeep Ganoria
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
ACBPositive Net Change GTBIFPositive Net Change VRNOFPositive Net Change CURLFPositive Net Change
marijuana medical
3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal
by Sundeep Ganoria
Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.
CGCPositive Net Change VFFPositive Net Change HITINo Net Change
marijuana medical pot-stocks
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification
by Sweta Killa
Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.
MJPositive Net Change CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change YOLOPositive Net Change CNBSPositive Net Change MSOSPositive Net Change WEEDPositive Net Change
etfs marijuana
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
by Sundeep Ganoria
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
CRBPNegative Net Change CGCPositive Net Change TLRYPositive Net Change HRMYPositive Net Change GTBIFPositive Net Change
biotechs marijuana medical pot-stocks
Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?
by Sundeep Ganoria
Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
earnings marijuana medical pot-stocks
Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?
by Sundeep Ganoria
Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.
TLRYPositive Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change
marijuana medical pot-stocks
Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold?
by Sundeep Ganoria
GTBIF slides 30% YTD as rising costs, flat revenues and tight U.S. rules weigh on margins and investor sentiment.
ACBPositive Net Change GTBIFPositive Net Change CRLBFPositive Net Change CURLFPositive Net Change
marijuana medical
Cannabis Stock Cresco Labs Plunges 24% YTD: Time to Sell or Hold?
by Sundeep Ganoria
CRLBF is down 24% YTD as U.S.-only exposure, falling margins and tighter regulations weigh on its cannabis business.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change CRLBFPositive Net Change
marijuana medical pot-stocks
Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment
by Sundeep Ganoria
HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.
JAZZNegative Net Change AXSMPositive Net Change HRMYPositive Net Change
biotechs marijuana medical
Cannabis Operator Curaleaf Plunges 46% YTD: Time to Sell or Hold?
by Sundeep Ganoria
CURLF dives 46% YTD as domestic headwinds outweigh global growth; is it time to cash out or wait for a rebound?
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change CURLFPositive Net Change
marijuana medical pot-stocks
Could the New Federal Bill Derail the U.S. Hemp Industry?
by Sundeep Ganoria
A proposed federal bill could upend the U.S. hemp market, threatening CBD and Delta-8 products now sold nationwide.
CGCPositive Net Change TLRYPositive Net Change CURLFPositive Net Change
marijuana medical pot-stocks
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell?
by Sundeep Ganoria
Canopy Growth surges 39% in three months as restructuring, margin gains and debt cuts renew investor interest.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change VFFPositive Net Change
marijuana medical pot-stocks
Cannabis Operator VFF Sells Fresh Produce Unit: How to Play the Stock?
by Sundeep Ganoria
After dropping its produce business, Village Farms sharpens its cannabis focus - boosting exports, margins and market share.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change VFFPositive Net Change
marijuana medical pot-stocks
Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?
by Sundeep Ganoria
ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.
CGCPositive Net Change TLRYPositive Net Change ACBPositive Net Change
marijuana medical pot-stocks
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
by Sundeep Ganoria
NVO, CRBP and SKYE are tapping into the booming obesity market with novel CBD-based therapies, offering alternatives amid intensifying GLP-1 competition.
NVOPositive Net Change LLYPositive Net Change CRBPNegative Net Change SKYENegative Net Change
biotechs marijuana medical pharmaceuticals
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
by Sundeep Ganoria
While CRBP's pipeline shows promise, the company's lack of marketed products remains a concern.
SNYNegative Net Change NVOPositive Net Change CRBPNegative Net Change
marijuana medical
Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?
by Sundeep Ganoria
TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.
PMNo Net Change JAZZNegative Net Change CRBPNegative Net Change TLRYPositive Net Change
marijuana medical pot-stocks